MA (EU) number EU/1/00/134/001

Invented name Lantus

EU/1/00/134/002

Strength

Route of administration Subcutaneous use

Immediate Packaging vial (glass)

Content

Pack size

100 Units/ml

Pharmaceutical form Solution for injection

5 ml

1 vial

Lantus

100 Units/ml

Solution for injection

Subcutaneous use

vial (glass)

5 ml

2 vials

EU/1/00/134/003

Lantus

100 Units/ml

Solution for injection

Subcutaneous use

vial (glass)

5 ml

5 vials

EU/1/00/134/004

Lantus

100 Units/ml

Solution for injection

Subcutaneous use

vial (glass)

5 ml

10 vials

EU/1/00/134/005

Lantus

100 Units/ml

Solution for injection

Subcutaneous use

cartridge (glass)

3 ml

4 cartridges

EU/1/00/134/006

Lantus

100 Units/ml

Solution for injection

Subcutaneous use

cartridge (glass)

3 ml

5 cartridges

EU/1/00/134/007

Lantus

100 Units/ml

Solution for injection

Subcutaneous use

cartridge (glass)

3 ml

10 cartridges

EU/1/00/134/012

Lantus

100 Units/ml

Solution for injection

Subcutaneous use

vial (glass)

10 ml

1 vial

EU/1/00/134/013

Lantus

100 Units/ml

Solution for injection

Subcutaneous use

cartridge (glass)

3 ml

1 cartridge

EU/1/00/134/014

Lantus

100 Units/ml

Solution for injection

Subcutaneous use

cartridge (glass)

3 ml

3 cartridges

EU/1/00/134/015

Lantus

100 Units/ml

Solution for injection

Subcutaneous use

cartridge (glass)

3 ml

6 cartridges

EU/1/00/134/016

Lantus

100 Units/ml

Solution for injection

Subcutaneous use

cartridge (glass)

3 ml

8 cartridges

EU/1/00/134/017

Lantus

100 Units/ml

Solution for injection

Subcutaneous use

cartridge (glass)

3 ml

9 cartridges

1/2

EU/1/00/134/030

Lantus

100 Units/ml

Solution for injection

Subcutaneous use

EU/1/00/134/031

Lantus

100 Units/ml

Solution for injection

Subcutaneous use

EU/1/00/134/032

Lantus

100 Units/ml

Solution for injection

Subcutaneous use

EU/1/00/134/033

Lantus

100 Units/ml

Solution for injection

Subcutaneous use

EU/1/00/134/034

Lantus

100 Units/ml

Solution for injection

Subcutaneous use

EU/1/00/134/035

Lantus

100 Units/ml

Solution for injection

Subcutaneous use

EU/1/00/134/036

Lantus

100 Units/ml

Solution for injection

Subcutaneous use

EU/1/00/134/037

Lantus

100 Units/ml

Solution for injection

Subcutaneous use

cartridge (glass) in pre-filled pen (SoloStar) cartridge (glass) in pre-filled pen (SoloStar) cartridge (glass) in pre-filled pen (SoloStar) cartridge (glass) in pre-filled pen (SoloStar) cartridge (glass) in pre-filled pen (SoloStar) cartridge (glass) in pre-filled pen (SoloStar) cartridge (glass) in pre-filled pen (SoloStar) cartridge (glass) in pre-filled pen (SoloStar)

3 ml

1 pre-filled pen

3 ml

3 pre-filled pens

3 ml

4 pre-filled pens

3 ml

5 pre-filled pens

3 ml

6 pre-filled pens

3 ml

8 pre-filled pens

3 ml

9 pre-filled pens

3 ml

10 pre-filled pens

Lantus : EPAR

MA (EU) number. Invented name. Strength. Pharmaceutical form. Route of administration. Immediate. Packaging. Content. Pack size. EU/1/00/134/001. Lantus.

43KB Sizes 70 Downloads 116 Views

Recommend Documents

Cuprior : EPAR - All Authorised presentations
Form. Route of. Administration. Immediate. Packaging. Pack size. EU/1/17/1199/001 Cuprior. 150 mg. Tablet. Oral use blister. (OPA/alu/PVC/al u). 72 tablets.

Cuprior : EPAR - All Authorised presentations
Page 1. MA (EU) number (Invented) name. Strength. Pharmaceutical. Form. Route of. Administration. Immediate. Packaging. Pack size. EU/1/17/1199/001 Cuprior. 150 mg. Tablet. Oral use blister. (OPA/alu/PVC/al u). 72 tablets.